Tcg Crossover Management, LLCFirm match from fund name (lower confidence)
TCG Crossover Fund II, L.P.
Open: no first sale reported; age from Form D filed Apr 2023 (approximate)
- Vintage
- Unknown
- Fund size
- $900M (Form D)
- Stages
- Pre-seed, Seed, Series A, Series B, Growth
- Sectors
- Biotech
- Regions
- Global
01 · Thesis
TCG Crossover invests in innovative biotech companies and visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines. It supports private and public companies and provides capital at any stage of a company's lifecycle.Inferred from the firm's website
02 · Initial check
$6M to $11.25M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Chen Yu, Managing Member of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideTCG Crossover (“TCGX”) is an investment firm focused on innovative biotech companies that invests in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.
We invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.
https://tcgcrossover.com/about-us/
06 · Sources
Last verified: Oct 28, 2026